[AMAG] AMAG Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 35.8 Change: 1 (2.87%)
Ext. hours: Change: 0 (0%)

chart AMAG

Refresh chart

Strongest Trends Summary For AMAG

AMAG is in the long-term down -85% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: AMAG Pharmaceuticals, Inc. develops and commercializes specialty pharmaceutical products. The company markets Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. It markets Feraheme in the United States and Canada; and as Rienso in the European Union. The company sells Feraheme to authorized wholesalers and specialty distributors. AMAG Pharmaceuticals, Inc. has a license, development, and commercialization agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Feraheme/Rienso as a therapeutic agent in Europe, certain Asia-Pacific countries, the Commonwealth of Independent States, Canada, India, and Turkey; and collaboration and exclusive license agreement with 3SBio for the development and commercialization of Feraheme as an IV iron rep

Fundamental Ratios
Shares Outstanding EPS1.11 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 385.93% Sales Growth - Q/Q38.41% P/E14.77
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA11.63% ROE26.74% ROI15.98%
Current Ratio1.71 Quick Ratio1.61 Long Term Debt/Equity1.51 Debt Ratio0.45
Gross Margin81.03% Operating Margin31.1% Net Profit Margin65.25% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities183.64 M Cash From Investing Activities-284.74 M Cash From Operating Activities71.69 M Gross Profit104.2 M
Net Profit33.26 M Operating Profit61.12 M Total Assets1.64 B Total Current Assets555.48 M
Total Current Liabilities323.97 M Total Debt483.2 M Total Liabilities926.3 M Total Revenue123.88 M
Technical Data
High 52 week25.65 Low 52 week10.34 Last close10.34 Last change-4.08%
RSI40.26 Average true range0.72 Beta0.76 Volume768.3 K
Simple moving average 20 days-8.89% Simple moving average 50 days-14.38% Simple moving average 200 days-41.9%
Performance Data
Performance Week-10.32% Performance Month-13.18% Performance Quart-38.12% Performance Half-56.92%
Performance Year-21.96% Performance Year-to-date-31.93% Volatility daily4.01% Volatility weekly8.97%
Volatility monthly18.39% Volatility yearly63.7% Relative Volume235.39% Average Volume747.72 K
New High New Low

News

2020-06-03 00:00:23 | Edited Transcript of AMAG earnings conference call or presentation 11-May-20 12:00pm GMT

2020-05-27 08:00:10 | AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference

2020-05-21 17:00:10 | AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million

2020-05-12 12:26:04 | AMAG Pharmaceuticals AMAG Reports Q1 Loss, Beats on Revenues

2020-05-11 12:00:37 | AMAG Pharmaceuticals Inc AMAG Q1 2020 Earnings Call Transcript

2020-05-11 09:45:01 | AMAG Pharmaceuticals AMAG Reports Q1 Loss, Tops Revenue Estimates

2020-05-11 07:32:04 | AMAG Pharmaceuticals: Q1 Earnings Insights

2020-05-11 07:00:10 | AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

2020-05-06 06:51:00 | Should You Buy This Stock That Makes "Viagra for Women"?

2020-05-05 06:13:01 | Does The AMAG Pharmaceuticals, Inc. NASDAQ:AMAG Share Price Fall With The Market?

2020-04-28 12:33:04 | AMAG Pharmaceuticals AMAG Earnings Expected to Grow: What to Know Ahead of Q1 Release

2020-04-28 07:00:10 | AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer

2020-04-27 16:30:10 | AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020

2020-04-16 08:00:10 | AMAG Pharmaceuticals Provides COVID-19 Company Update

2020-04-03 11:30:03 | AMAG Pharmaceuticals AMAG Down 21.5% Since Last Earnings Report: Can It Rebound?

2020-04-02 13:23:05 | LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day

2020-04-01 10:15:02 | 3 Drugmakers Still Worth Betting on Amid Coronavirus Woes

2020-03-25 12:00:04 | AMAG Pharmaceuticals AMAG Moves to Buy: Rationale Behind the Upgrade

2020-03-12 22:33:38 | Edited Transcript of AMAG earnings conference call or presentation 4-Mar-20 1:00pm GMT

2020-03-09 09:49:01 | AMAG Sees High Feraheme Sales, To Sell Women Healthcare Drugs

2020-03-05 08:21:01 | AMAG Q4 Loss Wider Than Expected, Revenues Beat Estimates

2020-03-04 08:35:01 | AMAG Pharmaceuticals AMAG Reports Q4 Loss, Tops Revenue Estimates

2020-03-04 07:00:10 | AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

2020-03-04 06:58:10 | AMAG Pharmaceuticals Announces Changes to Medical Development Organization

2020-03-01 08:31:17 | Have Insiders Been Buying AMAG Pharmaceuticals, Inc. NASDAQ:AMAG Shares?

2020-02-28 08:00:10 | AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Wednesday, March 4, 2020 at 8:00 a.m. ET

2020-02-26 08:46:01 | Is a Surprise Coming for AMAG This Earnings Season?

2020-02-19 08:53:01 | Should You Buy AMAG Pharmaceuticals AMAG Ahead of Earnings?

2020-02-14 16:34:36 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-02-14 08:00:10 | AMAG Pharmaceuticals to Participate in Upcoming Investor Conferences

2020-02-10 17:40:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-02-03 15:05:54 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AMAG Pharmaceuticals, Inc. – AMAG

2020-01-30 12:31:05 | AMAG Pharmaceuticals AMAG Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

2020-01-27 14:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-01-24 18:12:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-01-21 18:15:53 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-01-14 23:05:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-01-14 12:00:05 | AMAG Pharmaceuticals AMAG Upgraded to Buy: Here's Why

2020-01-10 18:08:11 | AMAG to Sell Women Healthcare Drugs, CEO Resigns, Stock Down

2020-01-10 09:59:00 | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. AMAG

2020-01-09 17:43:10 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG

2020-01-09 10:21:00 | Amag stock tumbles on CEO departure, divestiture plans

2020-01-09 09:55:44 | Waltham's Amag Pharma replacing CEO, cutting two products

2020-01-09 07:00:10 | AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review to Unlock Shareholder Value and Financial Update

2020-01-03 08:00:10 | AMAG Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

2019-12-18 08:00:10 | AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia Research

2019-12-13 11:12:26 | Hedge Funds Are Souring On AMAG Pharmaceuticals, Inc. AMAG

2019-12-06 08:00:10 | 12 Biotech Stocks Primed For A Short Squeeze

2019-12-02 08:20:35 | Those Who Purchased AMAG Pharmaceuticals NASDAQ:AMAG Shares Five Years Ago Have A 74% Loss To Show For It

2019-12-01 09:30:02 | Why Is AMAG Pharmaceuticals AMAG Up 9.7% Since Last Earnings Report?